Fennec Pharmaceuticals Valuation
| FENC Stock | USD 6.55 0.08 1.24% |
At this time, the firm appears to be undervalued. Fennec Pharmaceuticals shows a prevailing Real Value of $8.15 per share. The current price of the firm is $6.55. Our model computes the value of Fennec Pharmaceuticals from reviewing the firm fundamentals such as Profit Margin of (0.02) %, shares outstanding of 27.43 M, and Current Valuation of 168.91 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Fennec Pharmaceuticals' valuation include:
Price Book 57.9258 | Enterprise Value | Enterprise Value Ebitda 55.9499 | Price Sales 3.5966 | Forward PE 11.9332 |
Undervalued
Today
Please note that Fennec Pharmaceuticals' price fluctuation is slightly risky at this time. Calculation of the real value of Fennec Pharmaceuticals is based on 3 months time horizon. Increasing Fennec Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Fennec Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fennec Stock. However, Fennec Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.55 | Real 8.15 | Target 13.6 | Hype 6.51 | Naive 6.87 |
The real value of Fennec Stock, also known as its intrinsic value, is the underlying worth of Fennec Pharmaceuticals Company, which is reflected in its stock price. It is based on Fennec Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Fennec Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Fennec Pharmaceuticals helps investors to forecast how Fennec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fennec Pharmaceuticals more accurately as focusing exclusively on Fennec Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Fennec Pharmaceuticals' intrinsic value based on its ongoing forecasts of Fennec Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Fennec Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Fennec Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Fennec Pharmaceuticals Cash |
|
Fennec Valuation Trend
Comparing Fennec Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Fennec Pharmaceuticals uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Fennec Pharmaceuticals Total Value Analysis
Fennec Pharmaceuticals is currently estimated to have valuation of 168.91 M with market capitalization of 177.49 M, debt of 30.95 M, and cash on hands of 14.91 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Fennec Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
168.91 M | 177.49 M | 30.95 M | 14.91 M |
Fennec Pharmaceuticals Investor Information
About 16.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Fennec Pharmaceuticals had not issued any dividends in recent years. The entity had 1:3 split on the 5th of September 2014. Based on the key indicators related to Fennec Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Fennec Pharmaceuticals may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Fennec Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fennec Pharmaceuticals has an asset utilization ratio of 79.11 percent. This indicates that the Company is making $0.79 for each dollar of assets. An increasing asset utilization means that Fennec Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Fennec Pharmaceuticals Ownership Allocation
Fennec Pharmaceuticals holds a total of 27.43 Million outstanding shares. Over half of Fennec Pharmaceuticals' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Fennec Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 21.25 M. Net Loss for the year was (16.05 M) with profit before overhead, payroll, taxes, and interest of 46.15 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Fennec Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Fennec Pharmaceuticals and how it compares across the competition.
About Fennec Pharmaceuticals Valuation
The stock valuation mechanism determines Fennec Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Fennec Pharmaceuticals. We calculate exposure to Fennec Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fennec Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 23 M | 24.1 M | |
| Pretax Profit Margin | (0.68) | (0.71) | |
| Operating Profit Margin | (0.54) | (0.57) | |
| Net Loss | (0.68) | (0.71) | |
| Gross Profit Margin | 1.08 | 1.03 |
Fennec Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 26.6 M | |
| Forward Price Earnings | 11.9332 |
Fennec Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Fennec Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Fennec we look at many different elements of the entity such as Fennec's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Fennec Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Fennec Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Fennec Pharmaceuticals' worth.Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |